PubMed:25305591 / 0-344 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":195},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":195},"obj":"Sentence"}],"text":"VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.\nVasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase-activating polypeptide (PACAP) are two structurally-related neuropeptides with wi"}

{"project":"TEST-DiseaseOrPhenotypicFeature","denotations":[{"id":"T1","span":{"begin":98,"end":139},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"D004681"}],"text":"VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.\nVasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase-activating polypeptide (PACAP) are two structurally-related neuropeptides with wi"}

{"project":"TEST-ChemicalEntity","denotations":[{"id":"T1","span":{"begin":7,"end":36},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":196,"end":225},"obj":"ChemicalEntity"},{"id":"T3","span":{"begin":227,"end":230},"obj":"ChemicalEntity"},{"id":"T4","span":{"begin":274,"end":285},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"},{"id":"A2","pred":"ID:","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"},{"id":"A3","pred":"ID:","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"},{"id":"A4","pred":"ID:","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_15841"}],"text":"VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.\nVasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase-activating polypeptide (PACAP) are two structurally-related neuropeptides with wi"}

{"project":"TEST-OrganismTaxon","denotations":[{"id":"T1","span":{"begin":73,"end":77},"obj":"OrganismTaxon"}],"text":"VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.\nVasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase-activating polypeptide (PACAP) are two structurally-related neuropeptides with wi"}

{"project":"Test-GeneOrGeneProduct","denotations":[{"id":"T1","span":{"begin":0,"end":5},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":7,"end":45},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":196,"end":225},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":227,"end":230},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":236,"end":285},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":287,"end":292},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":323,"end":336},"obj":"GeneOrGeneProduct"}],"text":"VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.\nVasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase-activating polypeptide (PACAP) are two structurally-related neuropeptides with wi"}

{"project":"Test-merged-2","denotations":[{"id":"T57044","span":{"begin":7,"end":36},"obj":"ChemicalEntity"},{"id":"T5537","span":{"begin":196,"end":225},"obj":"ChemicalEntity"},{"id":"T90519","span":{"begin":227,"end":230},"obj":"ChemicalEntity"},{"id":"T81919","span":{"begin":274,"end":285},"obj":"ChemicalEntity"},{"id":"T79599","span":{"begin":0,"end":5},"obj":"GeneOrGeneProduct"},{"id":"T37040","span":{"begin":7,"end":45},"obj":"GeneOrGeneProduct"},{"id":"T60511","span":{"begin":196,"end":225},"obj":"GeneOrGeneProduct"},{"id":"T25011","span":{"begin":227,"end":230},"obj":"GeneOrGeneProduct"},{"id":"T10130","span":{"begin":236,"end":285},"obj":"GeneOrGeneProduct"},{"id":"T44134","span":{"begin":287,"end":292},"obj":"GeneOrGeneProduct"},{"id":"T9681","span":{"begin":323,"end":336},"obj":"GeneOrGeneProduct"},{"id":"T83856","span":{"begin":73,"end":77},"obj":"OrganismTaxon"},{"id":"T1","span":{"begin":98,"end":139},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A40450","pred":"ID:","subj":"T5537","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"},{"id":"A89178","pred":"ID:","subj":"T57044","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"},{"id":"A50295","pred":"ID:","subj":"T81919","obj":"http://purl.obolibrary.org/obo/CHEBI_15841"},{"id":"A33706","pred":"ID:","subj":"T90519","obj":"http://purl.obolibrary.org/obo/CHEBI_80331"},{"id":"A1","pred":"#label","subj":"T1","obj":"D004681"}],"text":"VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.\nVasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase-activating polypeptide (PACAP) are two structurally-related neuropeptides with wi"}